Enhance method development with state-of-the-art techniques and processes.
Analytical method development is the strategic selection and optimization of analytical techniques tailored to quantify a designated attribute of a drug substance or product. This multifaceted exercise employs a systematic framework for assessing and choosing methodologies that exhibit:
In addition to these criteria, the method should also be efficient and cost-effective.
We employ state-of-the-art techniques throughout our method development processes to ensure precise measurement of various critical quality attributes (CQA).
These methods encompass various types of analyses including:
For assessing defined attributes we utilize the following methods:
Identity
Isoform patterns by cIEF, CE-IEF
Quantity
Total protein content
UV absorbance
Impurity
HCP, HCD by RT-PCR
Aggregates by SE-HPLC or CE
Cell substrate impurities
Enzyme-linked immunosorbent assay (ELISA)
Reverse transcription-polymerase chain reaction (RT-PCR)
Biological Activity
Cell based assay
Binding assay (Octet® surface plasmon resonance (SPR), and ELISA assays)
Microbial testing
Microbiological tests (sterility etc.)
Endotoxin
Sterility testing
Membrane filtration
Direct Inoculation
We are a global Continuously Innovative Development and Manufacturing Organization (CIDMO), dedicated to changing the paradigm by which affordable biologic and biosimilar medicines are brought to market. Since Enzene’s inception, our innovative agility has enabled us to continually introduce transformative processes in biologics manufacturing that significantly increase product yields of complex biologics and monoclonal antibodies (mAbs) while reducing the manufacturing footprint and the cost of production.
Game-changing innovation is only the beginning, though. We are Enzene, and that means that our values of innovation, entrepreneurship, respect, candor, excellence, and integrity underscore everything we do from project management and communications to teamwork and ideation. To us, true partnership is about driving biotech innovation while doing so in a way that develops long-lasting trusted partnerships.
Your biologic deserves the most technologically advanced manufacturing process in the industry. And you deserve a new way to think about strategic partnership. Today is just the beginning.